Sam Mbulaiteye, MBChB, MPhil, MMed
Sam Mbulaiteye, MBChB, MPhil, MMed, senior investigator in the Infections and Immunoepidemiology Branch, in the Division of Cancer Epidemiology & Genetics of the National Cancer Institute, was recently recognized by the Lymphoma Foundation of America with its 2022 Scientist of the Year Award. As a part of this award, Dr. Mbulaiteye directed a donation from the foundation to a study site in Uganda to support medical care for children with Burkitt lymphoma.
Dr. Mbulaiteye is the principal investigator of the Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM) study, a case-control study being conducted in six rural regions of Uganda, Tanzania, and Kenya.
Eric A. Engels, MD, MPH
“This award is a very well-deserved recognition of Sam’s leadership of EMBLEM and his sustained efforts to understand the multifactorial etiology of Burkitt lymphoma,” said Eric A. Engels, MD, MPH, Chief of the Infections and Immunoepidemiology Branch. “His work will have an important impact on this major childhood cancer in sub-Saharan Africa.” Beyond his research, this award also commends Dr. Mbulaiteye’s outstanding commitment to mentorship.
